These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34497783)

  • 1. Clinical Characteristics and Outcomes Until 2 Years of Age in Preterm Infants With Typical Chest Imaging Findings of Bronchopulmonary Dysplasia: A Propensity Score Analysis.
    Ruan Q; Wang J; Shi Y
    Front Pediatr; 2021; 9():712516. PubMed ID: 34497783
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional support during the first week for infants with bronchopulmonary dysplasia and respiratory distress: a multicenter cohort study in China.
    Lin H; Bai G; Ge J; Chen X; He X; Ma X; Shi L; Du L; Chen Z
    BMC Pediatr; 2024 Apr; 24(1):238. PubMed ID: 38570780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g].
    Huang J; Lin XZ; Zheng Z; Wang L; Ou FF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1326-1333. PubMed ID: 36544414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
    Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants: A retrospective study in a medical center.
    Chang HP; Lien R; Chu SM; Lin JJ; Chiang MC
    Front Pediatr; 2023; 11():1055439. PubMed ID: 37020649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol in preterm infants at risk for or having respiratory distress syndrome.
    Howlett A; Ohlsson A; Plakkal N
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
    Chen X; Li H; Qiu X; Yang C; Walther FJ
    BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia.
    Gallini F; Coppola M; De Rose DU; Maggio L; Arena R; Romano V; Cota F; Ricci D; Romeo DM; Mercuri EM; Vento G
    Early Hum Dev; 2021 Jan; 152():105275. PubMed ID: 33227635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors for moderate/severe bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks: a multicenter retrospective analysis].
    Jiangsu Province Neonatal Perinatal Cooperation Network
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1104-1110. PubMed ID: 36305110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A retrospective cohort study on the correlation between early energy management and bronchopulmonary dysplasia in premature infants].
    Lin Q; Mu YJ; Song Y; Wang H
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):239-244. PubMed ID: 38378285
    [No Abstract]   [Full Text] [Related]  

  • 18. Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants.
    Mowitz ME; Ayyagari R; Gao W; Zhao J; Mangili A; Sarda SP
    Front Pediatr; 2019; 7():510. PubMed ID: 31921723
    [No Abstract]   [Full Text] [Related]  

  • 19. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.